These results are consistent with Lin et al. [23], who reported TPM1 downregulation in solid tumors including urothelial carcinoma, with expression inversely correlated with tumor grade, muscle invasiveness, and metastasis. The gene discussed is TPM1; the disease is urothelial carcinoma.